PAWZ - ETF AI Analysis
Top Page
ProShares Pet Care ETF (PAWZ)
Rating:67Neutral
Price Target:―
Positive Factors
Global Pet Care Focus
The fund targets companies tied to pet care across several countries, giving investors focused exposure to a growing, long-term theme.
Broad Sector Mix
Holdings spread across health care, consumer cyclical, consumer defensive, and other sectors help reduce reliance on any single industry within pet care.
Support from Defensive Holdings
Some large positions in more stable, defensive companies have shown stronger recent performance, helping offset weakness in other stocks.
Negative Factors
Weak Recent Performance
The ETF’s returns over the year to date and the last three months have been negative, showing that it has struggled in the current market.
Underperforming Top Holdings
Several of the largest positions, including key pet-focused stocks, have delivered weak performance, which weighs heavily on the fund’s results.
Moderately High Fees for a Niche ETF
The expense ratio is on the higher side compared with many broad market ETFs, meaning more of investors’ returns go toward fees.
PAWZ vs. SPDR S&P 500 ETF (SPY)
AUM34.37M
RegionGlobal
Expense Ratio0.50%
Beta0.64
IssuerProShares
Inception DateNov 05, 2018
Dividend Yield0.65%
Asset ClassEquity
Index TrackedFactSet Pet Care Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume1,815
30 Day Avg. Volume4,255
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
60.40Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering26
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PAWZ Summary
PAWZ is the ProShares Pet Care ETF, built to follow the FactSet Pet Care Index, a theme focused on the global pet care industry. It owns companies involved in pet food, vet services, pet medicine, and specialty pet retailers. Well-known holdings include Chewy, Zoetis, Merck, and Nestlé. Someone might invest in PAWZ to tap into long-term growth as people spend more on their pets and treat them like family, while also getting diversification across many pet-related businesses. A key risk is that it’s concentrated in the pet care sector, so its price can rise or fall sharply with trends in that industry and the overall stock market.
How much will it cost me?The ProShares Pet Care ETF (PAWZ) has an expense ratio of 0.50%, meaning you’ll pay $5 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed and focuses on a niche sector, which typically requires more specialized research and management.
What would affect this ETF?The ProShares Pet Care ETF could benefit from rising global pet ownership and increased spending on pet health and wellness, as pets are increasingly treated as family members. However, economic downturns or higher interest rates could negatively impact consumer spending on non-essential pet products and services, and regulatory changes in the healthcare sector might affect key holdings like Idexx Laboratories and Zoetis. The ETF’s global exposure also makes it sensitive to international market conditions and currency fluctuations.
PAWZ Top 10 Holdings
PAWZ is heavily leashed to the global pet-care theme, with a big tilt toward health care names like Zoetis and Idexx, both of which have been lagging lately and acting as a brake on returns. On the consumer side, Chewy has been especially weak, while Freshpet and Virbac have shown more mixed, stop-and-go progress. Offsetting some of that drag, Merck and UK retailer Pets at Home have been quietly rising. Overall, the fund is concentrated in pet-focused health care and retail, spread across the U.S., Europe, and Canada.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Chewy | 10.42% | $3.60M | $9.83B | -39.30% | 54 Neutral | |
| Zoetis | 10.25% | $3.54M | $32.12B | -50.37% | 74 Outperform | |
| Freshpet | 9.89% | $3.42M | $3.55B | 18.12% | 66 Neutral | |
| Idexx Laboratories | 9.84% | $3.40M | $43.88B | -13.73% | 78 Outperform | |
| Virbac SA | 7.35% | $2.54M | €2.78B | -3.67% | 75 Outperform | |
| Merck & Company | 4.92% | $1.70M | $376.37B | 74.60% | 80 Outperform | |
| Trupanion | 4.45% | $1.54M | $1.36B | -33.30% | 69 Neutral | |
| CVS Group plc | 4.37% | $1.51M | £882.68M | 0.31% | 66 Neutral | |
| Pets at Home | 4.36% | $1.51M | £928.09M | -9.83% | 74 Outperform | |
| Nestlé SA | 4.36% | $1.51M | CHF204.95B | 3.14% | 71 Outperform |
PAWZ Technical Analysis
Positive
―
Price Trends
49.77
Positive
49.74
Positive
51.99
Positive
Market Momentum
0.95
Negative
65.49
Neutral
81.87
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PAWZ, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 51.88, equal to the 50-day MA of 49.77, and equal to the 200-day MA of 51.99, indicating a bullish trend. The MACD of 0.95 indicates Negative momentum. The RSI at 65.49 is Neutral, neither overbought nor oversold. The STOCH value of 81.87 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PAWZ.
PAWZ Peer Comparison
Comparison Results
Performance Comparison
PAWZ
ProShares Pet Care ETF
53.52
-3.72
-6.50%
FFND
Future Fund Active ETF
―
―
―
LOGO
Tidal Trust III Alpha Brands Consumption Leaders ETF
―
―
―
OND
ProShares On-Demand ETF
―
―
―
YUNG
Corgi Longevity Consumer ETF
―
―
―
STYL
Corgi Lifestyle Brands ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents